Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Solentim Ltd
Solentim Ltd
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Cell-based therapy specialist Solentim expands European operations
The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within the EU
Finance
Solentim expands operations to China
“This direct investment will help us support and expand our activities,” said General Manager of Solentim China, Kun Peng
Research & Development
Solentim launches workflow for single stem cell cloning
The company aims to create, isolate and characterise the highest value cells for biological medicine development
Manufacturing
Solentim names new Chief Marketing Officer
Dr Mark Truesdale will join the cell line development (CLD) instrumentation specialist
Pharmaceutical
Solentim and SAL Scientific partner on cell line development
Collaboration will add SAL’s new growth supplements for cell culture media to Solentim's offerings
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Manufacturing
Simple, single-use TFF solution for R&D or manufacturing
Solentim claims significant time-saving advantages are provided by its new systems
Subscribe now